Company Filing History:
Years Active: 2017-2025
Title: The Innovations of Stefan Schoenert
Introduction
Stefan Schoenert is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of protease production. With a total of six patents to his name, Schoenert's work has advanced the understanding and application of recombinant technologies.
Latest Patents
Schoenert's latest patents focus on methods of recombinantly producing neutral protease. The disclosures provide the sequence of a preproenzyme, which serves as the precursor of a neutral protease. His work includes the expression of this enzyme in transformed host organisms and outlines methods for its production through recombinant means. The recombinantly produced neutral protease is particularly useful in cell biology, especially for tissue dissociation. Additionally, his patents disclose blends with other proteases and include nucleotide sequences encoding the neutral protease.
Career Highlights
Throughout his career, Schoenert has worked with prominent companies such as Roche Diagnostics Operations, Inc. and C-lecta GmbH. His experience in these organizations has allowed him to refine his expertise in biotechnology and patent development.
Collaborations
Schoenert has collaborated with notable colleagues, including Thomas Greiner-Stoeffele and Mathias Salomo. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Stefan Schoenert's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact the scientific community and advance the applications of recombinant technologies.